Andere talen Cosmos Holdings Inc. OTC Markets

Aandelen

COSM

US2214131078

Vertraagde tijd OTC Markets Andere beurzen 17:14:35 05-10-2021			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
4,51 ^USD	-5,65%		-2,45%	-.--%

19:42	Top stijgers in de middag	MT
15:17	Wall Street zal vrijdag hoger openen nu belangrijke inflatiecijfers aangeven dat de inflatie afkoelt	MT

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Top Midday Gainers	19:42
Wall Street Set to Open Higher Friday as Key Inflation Data Indicates Cooling Inflation	15:17
Investors Await Key Inflation Data as US Futures Trend Higher Pre-Bell	14:08
Top Premarket Gainers	13:42
Cosmos Health Inc. Signs Exclusive Distribution Agreement with Pharmalink for its Sky Premium Life Nutraceuticals in the UAE	27/06
Cosmos Health Strengthens Global Brain Tumor Market Position by Entering Agreement to Acquire Remaining Rights to WIPO-Filed CNS Cancer Drug Patent	19/06
Cosmos Health to Acquire Full Rights to Patent Targeting Central Nervous System Cancers	18/06
Cosmos Health Participated in Vitafoods Europe 2024, Receives Significant Interest and Numerous New Partnership Inquiries for its Sky Premium Life Nutraceuticals Brand	20/05
Cosmos Health : Change in Certifying Accountants - Form 8-K	26/04
Cosmos Health : RELATED PARTY TRANSACTION POLICIES AND PROCEDURES - Form 8-K	22/03
Cosmos Health Inc. Commences Development of Cloudscreen 2.0 the New Iteration of Its Next Generation AI Drug Repurposing Platform	21/03
Cosmos Health Inc. Receives Regulatory Approval to Sell Sky Premium Life Products in UAE Nutritional Supplements Market	18/03
Cosmos Health Successfully Completes Acquisition of Pharmatrade's Assets, Expects to Increase FY 2024 Annual Revenue by over $5 Million	01/03
Cosmos Health CEO, Greg Siokas, Purchases Shares in the Open Market, Showcasing His Confidence in the Company	21/02
Cosmos Health Bolsters Presence in $400Bn+ Global Generic Drugs Market with $3.5M Acquisition of 10-Drug Portfolio	19/01
Cosmos Health Acquires Rights to Patent for Drug Targeting Central Nervous System Cancers	07/12
Cosmos Health Files Patent Application for Obesity, Weight Management Product With European Patent Office	01/12
Tranche Update on Cosmos Health Inc.'s Equity Buyback Plan announced on January 24, 2023.	20/11
Cosmos Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	20/11
Cosmos Health Insider Bought Shares Worth $158,806, According to a Recent SEC Filing	12-10-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Cosmos Holdings Inc. OTC Markets

Aandelen

COSM

US2214131078

Andere talen

Filters